Peakdale Extends its Range of Medicinal Chemistry Services

23-Feb-2006

Peakdale Molecular Ltd announced the extension of its medicinal chemistry Services to further support its customers' drug discovery programmes. The services enable the Company to provide compounds with a superior starting point for hit discovery, resulting in significant savings for subsequent optimisation.

Peakdale's Medicinal Chemistry Services are designed to complement its customers' drug discovery initiatives through hit-to-lead and lead optimisation projects, patent protection projects, back-up chemotypes and fast follower candidate programmes. They also include the synthesis of chemogenetic arrays on an exclusive basis utilising Peakdale's unique, privileged scaffolds. The services are underpinned by Peakdale's strength in CADD, used to simulate drug-receptor interactions.

Other news from the department research and development

Most read news

More news from our other portals

Vis-à-Vis with UV/VIS

See the theme worlds for related content

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures
View topic world
Topic world Synthesis

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures